326 related articles for article (PubMed ID: 11328762)
1. Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients.
Maebashi K; Niimi M; Kudoh M; Fischer FJ; Makimura K; Niimi K; Piper RJ; Uchida K; Arisawa M; Cannon RD; Yamaguchi H
J Antimicrob Chemother; 2001 May; 47(5):527-36. PubMed ID: 11328762
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
[TBL] [Abstract][Full Text] [Related]
3. [Investigation of the expression levels of efflux pumps in fluconazole-resistant Candida albicans isolates].
Gulat S; Doluca Dereli M
Mikrobiyol Bul; 2014 Apr; 48(2):325-34. PubMed ID: 24819270
[TBL] [Abstract][Full Text] [Related]
4. Expression of Major Efflux Pumps in Fluconazole-Resistant Candida albicans.
Pourakbari B; Teymuri M; Mahmoudi S; Valian SK; Movahedi Z; Eshaghi H; Mamishi S
Infect Disord Drug Targets; 2017; 17(3):178-184. PubMed ID: 28558643
[TBL] [Abstract][Full Text] [Related]
5. ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates.
Holmes AR; Lin YH; Niimi K; Lamping E; Keniya M; Niimi M; Tanabe K; Monk BC; Cannon RD
Antimicrob Agents Chemother; 2008 Nov; 52(11):3851-62. PubMed ID: 18710914
[TBL] [Abstract][Full Text] [Related]
6. [Investigation of mutations in transcription factors of efflux pump genes in fluconazole-resistant Candida albicans strains overexpressing the efflux pumps].
Kalkandelen KT; Doluca Dereli M
Mikrobiyol Bul; 2015 Oct; 49(4):609-18. PubMed ID: 26649419
[TBL] [Abstract][Full Text] [Related]
7. Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis.
Moran GP; Sanglard D; Donnelly SM; Shanley DB; Sullivan DJ; Coleman DC
Antimicrob Agents Chemother; 1998 Jul; 42(7):1819-30. PubMed ID: 9661028
[TBL] [Abstract][Full Text] [Related]
8. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.
Sanglard D; Ischer F; Monod M; Bille J
Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():405-416. PubMed ID: 9043118
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional analyses of antifungal drug resistance in Candida albicans.
Lyons CN; White TC
Antimicrob Agents Chemother; 2000 Sep; 44(9):2296-303. PubMed ID: 10952571
[TBL] [Abstract][Full Text] [Related]
10. A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole.
Calabrese D; Bille J; Sanglard D
Microbiology (Reading); 2000 Nov; 146 ( Pt 11)():2743-2754. PubMed ID: 11065353
[TBL] [Abstract][Full Text] [Related]
11. Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance.
Tsao S; Rahkhoodaee F; Raymond M
Antimicrob Agents Chemother; 2009 Apr; 53(4):1344-52. PubMed ID: 19223631
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
Mane A; Vidhate P; Kusro C; Waman V; Saxena V; Kulkarni-Kale U; Risbud A
Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048
[TBL] [Abstract][Full Text] [Related]
13. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors.
Sanglard D; Ischer F; Monod M; Bille J
Antimicrob Agents Chemother; 1996 Oct; 40(10):2300-5. PubMed ID: 8891134
[TBL] [Abstract][Full Text] [Related]
14. Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance.
Niimi M; Niimi K; Takano Y; Holmes AR; Fischer FJ; Uehara Y; Cannon RD
J Antimicrob Chemother; 2004 Dec; 54(6):999-1006. PubMed ID: 15486081
[TBL] [Abstract][Full Text] [Related]
15. Antifungal drug resistance in pathogenic fungi.
Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of action of tetrandrine, a natural inhibitor of Candida albicans drug efflux pumps.
Zhang H; Gao A; Li F; Zhang G; Ho HI; Liao W
Yakugaku Zasshi; 2009 May; 129(5):623-30. PubMed ID: 19420894
[TBL] [Abstract][Full Text] [Related]
17. Synthetic Organotellurium Compounds Sensitize Drug-Resistant Candida albicans Clinical Isolates to Fluconazole.
Reis de Sá LF; Toledo FT; Gonçalves AC; Sousa BA; Dos Santos AA; Brasil PF; Duarte da Silva VA; Tessis AC; Ramos JA; Carvalho MA; Lamping E; Ferreira-Pereira A
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821447
[TBL] [Abstract][Full Text] [Related]
18. Fungicidal synergism of fluconazole and cyclosporine in Candida albicans is not dependent on multidrug efflux transporters encoded by the CDR1, CDR2, CaMDR1, and FLU1 genes.
Marchetti O; Moreillon P; Entenza JM; Vouillamoz J; Glauser MP; Bille J; Sanglard D
Antimicrob Agents Chemother; 2003 May; 47(5):1565-70. PubMed ID: 12709323
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibility.
Niimi K; Maki K; Ikeda F; Holmes AR; Lamping E; Niimi M; Monk BC; Cannon RD
Antimicrob Agents Chemother; 2006 Apr; 50(4):1148-55. PubMed ID: 16569823
[TBL] [Abstract][Full Text] [Related]
20. Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters.
Karababa M; Coste AT; Rognon B; Bille J; Sanglard D
Antimicrob Agents Chemother; 2004 Aug; 48(8):3064-79. PubMed ID: 15273122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
